+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Disposable Plastic Blood Bag Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region

  • PDF Icon

    Report

  • 92 Pages
  • March 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5948224
Global market for disposable plastic bags of blood has emerged as a pivotal development, offering groundbreaking solutions for the storage, collection, transportation, and transfusion of blood and its components, including red blood cells (RBCs), white blood cells (WBCs), and platelets. Manufactured predominantly from Polyvinyl Chloride (PVC) and other plastic materials, these bags are tailored to meet the stringent demands of medical protocols through processes that encompass extrusion, welding, sterilization, compounding, molding, solution preparation, and meticulous inspection to prevent contamination.

Financial Milestones and Market Expansion

The year 2014 marked a significant milestone, with the global market for disposable plastic bags of blood recording revenues of USD 480 Mn. Projections indicate a promising future, with anticipated revenues escalating to USD 925 Mn by the close of 2031. This period is expected to witness a robust Compound Annual Growth Rate (CAGR) of 10.0%, underscoring the dynamic expansion and the vital role these bags play in modern healthcare.

Driving Forces Behind the Market Growth

The substantial growth of the disposable plastic bags of blood market is attributed to several key factors. An increasing prevalence of lifestyle and chronic diseases, coupled with a rising aging population, has fueled the demand for these bags. Additionally, their advanced features, designed to enhance blood storage and transfusion practices, have further propelled market growth. Government initiatives aimed at raising awareness about the importance of blood donation have also played a crucial role in this upward trajectory.

Challenges and Opportunities

Despite the positive outlook, the market faces challenges, including risks associated with blood transfusion, a lack of awareness, and inadequate blood collection and storage infrastructure globally. Furthermore, the dearth of primary healthcare infrastructure in several developing nations poses a significant hurdle. However, these challenges present opportunities for innovation and improvement, encouraging the development of safer, more efficient blood storage solutions.

Geographical Insights

Geographically, the global market for disposable plastic bags of blood is segmented into North America, Europe, and Asia. North America is expected to maintain its dominance in this market.

Within the North American market, the U.S. represents the largest segment, followed by Canada, primarily due to the increasing prevalence of blood-related disorders in this region.

In the global market, the Asia region is forecasted to witness higher growth rates over the next five years, driven by its large population base and growing demand for blood transfusion procedures. Countries such as India and China are expected to experience rapid growth in the global market for disposable plastic bags of blood within the Asian region.

Innovation and Industry Dynamics

Recent trends in the market reveal a growing adoption of RFID technology in blood bags, enhancing tracking and safety. Mergers and acquisitions among companies have also been a notable trend, fostering consolidation and innovation within the industry.

Some of the major players in the disposable plastic blood bags market:

  • Terumo Corporation.
  • Fresenius SE & Co.
  • KGaA.
  • Grifols.
  • S.A.
  • MacoPharma SA.
  • Haemonetics Corporation.
  • Other.

Segmentation of the Market

The global market for disposable plastic bags of blood is analyzed through a dual lens of product type and end-user type. Product types include Single, Double, Triple, and Quadruple Blood Bags, catering to a range of storage and transfusion needs. End-users are primarily Blood Banks, Hospitals and Healthcare Institutes, and Home Healthcare services, each with unique requirements that these products aim to fulfill.

By Type

  • Single Blood Bags
  • Double Blood Bags
  • Triple Blood Bags
  • Quadruple Blood Bags

By End Users

  • Hospital and Healthcare Institutes
  • Blood Banks
  • Home Healthcare

By Geography

  • North America
  • Europe
  • Asia


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Disposable Plastic Blood Bag Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Disposable Plastic Blood Bag Market Outlook, 2018 - 2031
3.1. Global Disposable Plastic Blood Bag Market Outlook, by Type, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Single Blood Bags
3.1.1.2. Double Blood Bags
3.1.1.3. Triple Blood Bags
3.1.1.4. Quadruple Blood Bags
3.2. Global Disposable Plastic Blood Bag Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospital and Healthcare Institutes
3.2.1.2. Blood Banks
3.2.1.3. Home Healthcare
3.3. Global Disposable Plastic Blood Bag Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Disposable Plastic Blood Bag Market Outlook, 2018 - 2031
4.1. North America Disposable Plastic Blood Bag Market Outlook, by Type, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Single Blood Bags
4.1.1.2. Double Blood Bags
4.1.1.3. Triple Blood Bags
4.1.1.4. Quadruple Blood Bags
4.2. North America Disposable Plastic Blood Bag Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospital and Healthcare Institutes
4.2.1.2. Blood Banks
4.2.1.3. Home Healthcare
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Disposable Plastic Blood Bag Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
4.3.1.2. U.S. Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
4.3.1.3. Canada Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
4.3.1.4. Canada Disposable Plastic Blood Bag Market by End User, Value (US$Mn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Disposable Plastic Blood Bag Market Outlook, 2018 - 2031
5.1. Europe Disposable Plastic Blood Bag Market Outlook, by Type, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Single Blood Bags
5.1.1.2. Double Blood Bags
5.1.1.3. Triple Blood Bags
5.1.1.4. Quadruple Blood Bags
5.2. Europe Disposable Plastic Blood Bag Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospital and Healthcare Institutes
5.2.1.2. Blood Banks
5.2.1.3. Home Healthcare
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Disposable Plastic Blood Bag Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
5.3.1.2. Germany Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.3. U.K. Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
5.3.1.4. U.K. Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.5. France Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
5.3.1.6. France Disposable Plastic Blood Bag Market by End User, Value (US$Mn), 2018 - 2031
5.3.1.7. Italy Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
5.3.1.8. Italy Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.9. Turkey Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
5.3.1.10. Turkey Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.11. Russia Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
5.3.1.12. Russia Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.13. Rest of Europe Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
5.3.1.14. Rest of Europe Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Disposable Plastic Blood Bag Market Outlook, 2018 - 2031
6.1. Asia Pacific Disposable Plastic Blood Bag Market Outlook, by Type, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Single Blood Bags
6.1.1.2. Double Blood Bags
6.1.1.3. Triple Blood Bags
6.1.1.4. Quadruple Blood Bags
6.2. Asia Pacific Disposable Plastic Blood Bag Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospital and Healthcare Institutes
6.2.1.2. Blood Banks
6.2.1.3. Home Healthcare
6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Disposable Plastic Blood Bag Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
6.3.1.2. China Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.3. Japan Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
6.3.1.4. Japan Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.5. South Korea Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
6.3.1.6. South Korea Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.7. India Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
6.3.1.8. India Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.9. Southeast Asia Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
6.3.1.10. Southeast Asia Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Disposable Plastic Blood Bag Market Outlook, 2018 - 2031
7.1. Latin America Disposable Plastic Blood Bag Market Outlook, by Type, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Single Blood Bags
7.1.1.2. Double Blood Bags
7.1.1.3. Triple Blood Bags
7.1.1.4. Quadruple Blood Bags
7.2. Latin America Disposable Plastic Blood Bag Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hospital and Healthcare Institutes
7.2.1.2. Blood Banks
7.2.1.3. Home Healthcare
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Disposable Plastic Blood Bag Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
7.3.1.2. Brazil Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.3. Mexico Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
7.3.1.4. Mexico Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.5. Argentina Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
7.3.1.6. Argentina Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.7. Rest of Latin America Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
7.3.1.8. Rest of Latin America Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Disposable Plastic Blood Bag Market Outlook, 2018 - 2031
8.1. Middle East & Africa Disposable Plastic Blood Bag Market Outlook, by Type, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Single Blood Bags
8.1.1.2. Double Blood Bags
8.1.1.3. Triple Blood Bags
8.1.1.4. Quadruple Blood Bags
8.2. Middle East & Africa Disposable Plastic Blood Bag Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospital and Healthcare Institutes
8.2.1.2. Blood Banks
8.2.1.3. Home Healthcare
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Disposable Plastic Blood Bag Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
8.3.1.2. GCC Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.3. South Africa Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
8.3.1.4. South Africa Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.5. Egypt Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
8.3.1.6. Egypt Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.7. Nigeria Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
8.3.1.8. Nigeria Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Disposable Plastic Blood Bag Market by Type, Value (US$ Mn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Disposable Plastic Blood Bag Market by End User, Value (US$ Mn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Type vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Haemonetics Corporation
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Grifols, S.A.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. JMS Co., Ltd.
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Kawasumi Laboratories, Inc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. AdvaCare Pharma
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Fresenius SE & Co. KGaA
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Terumo Corporation
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. MacoPharma, S.A.
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. GenesisBPS
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. SURU International Pvt. Ltd.
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Shanghai Transfusion Technology Co., Ltd.
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Sichuan Nigale Biomedical Co., Ltd.
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Neomedic Limited
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Shandong Weigao Group Medical Polymer Co., Ltd.
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
10. Appendix
10.1.Research Methodology
10.2.Report Assumptions
10.3.Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Terumo Corporation.
  • Fresenius SE & Co.
  • KGaA.
  • Grifols.
  • S.A.
  • MacoPharma SA.
  • Haemonetics Corporation.

Methodology

Loading
LOADING...